Genetic Technologies Ltd (GTG) — Capital Reinvestment Ratio
Latest as of March 2022:
0.24x
Genetic Technologies Ltd (GTG) has a Capital Reinvestment Ratio of 0.24x as of March 2022, meaning it reinvests 0% of its operating cash flow (AU$337.45K) in capital expenditures (AU$79.79K). See GTG FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.24x
Capex / Operating Cash Flow
Operating Cash Flow
AU$337.45K
AUD
Capital Expenditures
AU$79.79K
AUD
Data as of
Mar 2022
Most recent filing
Genetic Technologies Ltd Capital Reinvestment Ratio (2007–2011)
This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Genetic Technologies Ltd (2007–2011)
Year-by-year Capital Reinvestment Ratio for Genetic Technologies Ltd from 2007 to 2011. For live market cap and broader valuation context, see Genetic Technologies Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.06x | AU$2.23 Million | AU$139.68K | ▼ -77.6% |
| 2008 | 0.28x | AU$423.68K | AU$118.26K | ▲ +286.6% |
| 2007 | 0.07x | AU$2.20 Million | AU$158.87K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow